RECURRENT MELANOMA
Clinical trials for RECURRENT MELANOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MELANOMA trials appear
Sign up with your email to follow new studies for RECURRENT MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to outsmart tough cancers that resist standard treatment
Disease control Recruiting nowThis study is testing whether combining two drugs, cabozantinib and nivolumab, can help control advanced melanoma or head and neck cancer that has worsened despite standard immunotherapy. It will enroll about 150 adults whose cancer has progressed on prior treatment. A key goal i…
Matched conditions: RECURRENT MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
First-in-Human trial tests engineered immune cells to fight tough melanoma
Disease control Recruiting nowThis is an early-stage study to find a safe and effective dose of a new cell therapy for people with advanced melanoma that has come back or stopped responding to standard treatments. Doctors will give participants immune cells (NK cells) that have been specially engineered in a …
Matched conditions: RECURRENT MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC